Document Type : Research Articles
Universidad Científica del Sur, Lima, Perú.
Latin American Network for Cancer Research (LAN–CANCER), Lima, Peru.
Cancer Center, The American British Cowdray Medical Center, Mexico City, Mexico.
Universidad Católica Los Ángeles de Chimbote, Instituto de Investigación, Chimbote, Perú.
Department of Clinical Sciences and Community Health, Università degli Studi di Milano 20133, Milan, Italy.
Thoracic Oncology Program, Memorial Cancer Institute, Florida International University (FIU), Miami, Florida, USA.
Objectives: Lung cancer continues to be the leading cause of cancer-related deathworldwide. Have been reported high mortality rates from lung cancer in Latin America, but the disparities within the regions of Peru and under-reporting death certification reported prevent the inclusion of Peru in analysis of the mortality trends for lung cancer. We evaluated lung cancer mortality trends and smoking prevalence in Peru and its geographical areas. Materials and Methods: We obtained the data from the registry of the Peruvian Ministry of Health between 2008 and 2017. Mortality rates per 100,000 person-years were computed using the world’s SEGI population and trends were analyzed using the Joinpoint regression Program Version 4.7.0. Smoking prevalence was estimated from the Demographic and Family Health Survey. Results: In Peru, mortality rates were roughly 1.3 times higher in males than in females. The coast region had significant downward trends among males, whereas the highlands region had significant upward trends among females. According to provinces, Apurimac showed an annually significant rise in both sexes (+10.6% in males, and +11.6% in females). In general, smoking prevalence was higher in males compared to females, principally among young adults. Conclusions: Peru showed downward mortality trends in the last decade with variability across regions. Males had a higher smoking prevalence, principally among young adults. Public health interventions for smoking reduction should be implemented to reduce lung cancer mortality.